Viral Timeline - Andi West Web and IT

Viral Timeline

Viral Timeline

Viral Timeline

1999

Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier

2003

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

2007

Studying Coronavirus–Host Protein Interactions

A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice

2014

NIHU.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS

2016

SARS-like WIV1-CoV poised for human emergence

2018

US State Dept. Cables warning of security and containment issues at the WIV

2020

***Authors of 2015 chimera virus paper failed to mention NIH NIAID funding Via Ecohealth Alliance. Corrected in February of 2020

EcoHealth Alliance Director Peter Daszeck goes on 100 news broadcasts and claims no viruses related to Sars or Sars2 at WIV

Danielle Anderson goes on World News claiming virus is not airborne and creates Wet Market origin myth

2002

Systematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59

2006

Construction of a Severe Acute Respiratory Syndrome Coronavirus Infectious cDNA Clone and a Replicon To Study Coronavirus RNA Synthesis

2008

Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice

2015

Faucci Approves funding to move virus research to WIV using EcoHealth Alliance as Proxy

Chimera Virus created with NIH funding ***

2017

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus

2019

Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing

Sar-Cov-2 emergence (not from a wet market as is widely believed)

1999

Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier

2002

Systematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59

2003

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

2006

Construction of a Severe Acute Respiratory Syndrome Coronavirus Infectious cDNA Clone and a Replicon To Study Coronavirus RNA Synthesis

2007

Studying Coronavirus–Host Protein Interactions

A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice

2008

Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice

2014

NIHU.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS

2015

Faucci Approves funding to move virus research to WIV using EcoHealth Alliance as Proxy

Chimera Virus created with NIH funding ***

2016

SARS-like WIV1-CoV poised for human emergence

2017

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus

2018

US State Dept. Cables warning of security and containment issues at the WIV

2019

Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing

Sar-Cov-2 emergence (not from a wet market as is widely believed)

2020

***Authors of 2015 chimera virus paper failed to mention NIH NIAID funding Via Ecohealth Alliance. Corrected in February of 2020

EcoHealth Alliance Director Peter Daszeck goes on 100 news broadcasts and claims no viruses related to Sars or Sars2 at WIV

Danielle Anderson goes on World News claiming virus is not airborne and creates Wet Market origin myth

Return to Reality